Introduction Endometrial hyperplasia is a precancerous lesion of the endometrium, commonly presenting with uterine bleeding. If managed expectantly, it frequently progresses to endometrial carcinoma, ...

However, this symptom is not specific and can also occur with endometrial hyperplasia and certain other nonmalignant conditions of the vagina. Nonbloody vaginal discharge can also be a ...

Many PCOS patients have unopposed estrogen stimulation for prolonged periods of time and are thus at risk for endometrial hyperplasia or endometrial carcinoma. Any PCOS patient with prolonged ...

It's a natural part of aging, but at some point, it can lead to a condition called benign prostatic hyperplasia (BPH). Benign prostatic hyperplasia is a condition that causes your prostate to grow ...

Pseudoangiomatous stromal hyperplasia is a rare condition that may be mistaken for breast cancer, but researchers haven’t found a connection between the two conditions. Pseudoangiomatous stromal ...

Pathogenesis is the term that is used to describe the origin and development of a disease.

Bacterial pathogenesis is the process by which bacteria infect and cause disease in a host. Not all bacteria are pathogens and have the ability for pathogenesis (also known as virulence).

Menarche occurs towards the end of puberty when the complex cascade of hormonal events results in sufficient ovarian oestrogens to promote endometrial proliferation ... and late onset congenital ...

Aldo-keto reductase family 1 member B10 (AKR1B10) is a member of the AKR1B subfamily. It is mainly found in cytoplasm, and it is typically expressed in the stomach and intestines. Given that its ...

Mol JA, Lantinga-van LeeuwenIS, Van Garderen E, Rijnberk A. Progestin-induced Mammary Growth Hormone (GH) Production. In: “The Biology of the Mammary Gland”. (J.A ...

The functions of various organs are influenced by the androgen receptor (AR). The efficient AR is required for the sex differentiation or puberty as well as for reproduction in adulthood. Mutations of ...

Both the PCOS group and control group included women aged ≤42 years and excluded individuals with abnormal thyroid function, type 2 diabetes, Cushing’s syndrome, congenital adrenal hyperplasia, ...